VCP and psoriasis: FABP5 interacts with VCP, which is a crucial player in NF-κB activation, and their silencing inhibits NF-κB signaling and neutrophil chemotaxis, suggesting a role in the molecular mechanisms underlying psoriasis pathogenesis [70].